X
08Aug

FDA Releases New Warning Letter on Human and Animal Hemp CBD Products

On July 22, 2019, the Food and Drug Administration (“FDA”) released its fourth warning letter for cannabidiol (“CBD”) related products since the enactment of the 2018 Federal Farm Bill in December. Though not a formal action or rule-making by the...
By: Miller & Martin PLLC
Source Url: https://www.jdsupra.com/legalnews/fda-releases-new-warning-letter-on-18252/

Related

Never, ever, ever assume! (or, how a stuck shoe is like a construction project assumption) (law note)

This summer, I had the fortune of taking a trip to Europe. The first place I visited was Amsterdam...

Read More >

Increase in HSR Reportability Thresholds and Other HSR Developments

On January 28, 2020, the Federal Trade Commission (FTC) announced the annual adjustment of the thres...

Read More >

Trump Administration Proposes Transparency Rule for Group Health Plans and Insurers

On November 15, 2019, the Department of Health and Human Services, the Department of Labor, and the ...

Read More >

Antitrust in focus

This newsletter is our take on the antitrust developments we think are most interesting to your busi...

Read More >

M&T Bank Will Pay $100,000 to Settle EEOC Disability Discrimination Lawsuit

Bank Failed to Accommodate Manager With Pregnancy-Related Disability, Federal Agency Charged - BAL...

Read More >

First Circuit Rules That Private Equity Funds Are Not Responsible For Portfolio Company Withdrawal Liability

Seyfarth Synopsis: In a long-awaited decision with significant impact for the private equity industr...

Read More >